Advances in Uveitis
Track:
Uveitis
When:
3:15 PM, Friday 25 Jun 2021
(1 hour 30 minutes)
Learning Objectives
At the end of this session, participants are able to:
- Describe the treatment of severe uveitis
- Use imaging technique to follow uveitis
CanMEDS Roles: Medical
Expert, Scholar
Sub Sessions
Comparative Efficacy and Safety of Adalimumab and Infliximab for Treatment of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis
3:20 PM
(10 minutes)
Part of:
Advances in Uveitis
Speaker
Felicia Tai
Paper Presentation | Présentation d'article
Efficacy of intravitreal dexamethasone implant monotherapy for the treatment of macular edema in non-infectious uveitis
3:30 PM
(10 minutes)
Part of:
Advances in Uveitis
Speaker
Rishi B. Gupta
Paper Presentation | Présentation d'article
Discussion
Cannabinoid use in Uveitis; A survey of Vogt-Koyanagi-Harada patients
4:05 PM
(10 minutes)
Part of:
Advances in Uveitis
Speaker
David Plemel
Paper Presentation | Présentation d'article
Intravitreal injection of COX-2 acetylating immune-resolvents (CAIRs) for the treatment of ocular inflammation in an animal model of uveitis.
4:15 PM
(10 minutes)
Part of:
Advances in Uveitis
Speaker
Anastasiya Vinokurtseva
Paper Presentation | Présentation d'article
Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis Associated Uveitis in the Canadian Context: Adolopment of the American College of Rheumatology/Arthritis Foundation Guidelines
4:25 PM
(19 minutes)
Part of:
Advances in Uveitis
Presenter
Chloe Gottlieb
Paper Presentation | Présentation d'article